NEW YORK (GenomeWeb News) – BioInquire, an Athens, Ga.-based bioinformatics company, said today that is has won a $747,000 Phase II Small Business Technology Transfer grant.
The company plans to use the two-year National Institutes of Health grant to continue to develop its ProteoIQ software suite. The software is designed and distributed for use in academic, pharmaceutical, biotechnology, and molecular diagnostic labs that use mass spectrometry proteomics research techniques.
"While software applications exist for validation and quantitation of MS/MS data, no current product adequately addresses the needs of researchers doing large scale clinical proteomics," James Atwood, co-founder and CEO of BioInquire, said in a statement. "The award will allow us to bridge that technology gap by providing a software solution that will enable the comparison of proteomic data across hundreds of patients."